Final answer:
FFP is used for replacing clotting factors in the treatment of bleeding disorders related to coagulation deficiencies. It contains a wide array of clotting factors, beneficial in restoring the coagulation cascade, though there are specific treatments for certain conditions like Hemophilia B.
Step-by-step explanation:
FFP, or Fresh Frozen Plasma, is primarily used for C) Replacing clotting factors in patients with deficiencies or disorders related to coagulation. It contains all of the clotting factors, without the cells that make up whole blood. When FFP is administered, it delivers a wide array of clotting factors, including but not limited to fibrinogen, factor VIII, and factor IX, therefore helping in the coagulation process to form a blood clot.
FFP may also help in raising the concentration of fibrinogen and treating bleeding conditions such as disseminated intravascular coagulation (DIC), where large amounts of clotting factors are consumed rapidly.
In factor IX deficiency, also known as Hemophilia B, treatment with FFP is possible but not preferred mainly because concentrated factor IX products are available and pose less risk of volume overload.
Blood volume expansion is a secondary effect of FFP, but there are other more efficient and less risky methods for volume expansion, such as crystalloid and colloid solutions.